Category: EIN Presswire

ORLANDO, FL, UNITED STATES, March 17, 2026 /EINPresswire.com/ — Jon “Money Mase” Mason, nationally recognized sales trainer, entrepreneur, and leadership coach, is helping a new generation of sales professionals achieve success from the very beginning of their careers through his results driven training programs. At a time when many new salespeople struggle to gain traction, Mason’s methodology focuses on accelerating performance, building confidence, and enabling participants to generate income early rather than waiting months for results.

Entering the sales profession can be daunting. New hires often face steep expectations, unfamiliar processes, and the pressure to produce revenue without a clear roadmap for doing so. Mason’s programs address this challenge directly by providing structured systems that transform prospecting and selling into repeatable, learnable skills.

“Early wins change everything,” Mason said. “When new sales professionals see results quickly, they develop belief in themselves and in the process. That belief drives activity, and activity drives long term success.”
Central to Mason’s approach is the concept of disciplined prospecting. Rather than treating outreach as an unpredictable art, he teaches it as a systematic process grounded in daily action. Participants learn how to identify qualified prospects, initiate meaningful conversations, handle objections with confidence, and guide prospects toward decisions without relying on high pressure tactics.
M
ason emphasizes authenticity and relationship building as key drivers of sustainable performance. His training moves beyond rigid scripts, encouraging professionals to communicate clearly, listen actively, and position themselves as trusted advisors rather than transactional sellers. This approach not only improves conversion rates but also fosters long term client relationships.

Another critical component of the program is mindset development. Rejection, uncertainty, and performance pressure can quickly derail newcomers. Mason equips participants with tools to manage setbacks, maintain focus, and develop resilience. By reframing challenges as opportunities for growth, new salespeople learn to persist through obstacles that might otherwise cause them to leave the profession.
The training is highly practical and application focused. Workshops incorporate real world scenarios, role playing exercises, and immediate implementation strategies so participants can apply what they learn right away. This hands on format ensures that individuals leave with actionable skills rather than theoretical knowledge.

Organizations that implement Mason’s methodology often experience faster onboarding timelines and improved retention. When new hires begin producing revenue sooner, morale increases across teams and the overall cost of training decreases. Leaders also gain structured frameworks for coaching, accountability, and performance measurement.

In addition to individual contributors, Mason provides guidance for sales managers seeking to build high performing cultures. His leadership insights emphasize clear expectations, measurable activity standards, and consistent support. By aligning team behavior with proven processes, organizations can create sustainable growth rather than relying on sporadic high performers.

Mason’s impact extends across industries including financial services, real estate, technology, professional services, and business to business sales. His programs are delivered through live events, corporate training sessions, keynote presentations, and ongoing coaching engagements tailored to each client’s objectives.
The demand for effective sales training continues to rise as businesses face increased competition and evolving buyer behavior. Decision makers are more informed than ever, making disciplined outreach and authentic communication essential for success. Mason’s framework equips professionals with the tools needed to stand out in this environment.

“Sales is one of the most powerful skills a person can develop,” Mason added. “When individuals learn how to create value, communicate effectively, and serve clients at a high level, they unlock opportunities that can transform their lives.”

About Jon “Money Mase” Mason
Jon “Money Mase” Mason is an entrepreneur, author, sales trainer, and leadership coach known for helping individuals and organizations build predictable pipelines and close deals with confidence. Through his signature training programs, he equips professionals with the skills, discipline, and mindset required to achieve consistent high performance.

Jon Mason
LMT Financial
+1 954-461-3009
email us here
Visit us on social media:
Instagram

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

BOYNTON BEACH, FL, UNITED STATES, March 17, 2026 /EINPresswire.com/ — Pro Psychological Analysis, a professional provider of clinical assessment services, is introducing specialized psychological evaluations designed to support immigrants navigating complex legal processes. These services are structured to assist immigration attorneys and applicants who require detailed psychological documentation as part of asylum claims and extreme hardship waivers.

Psychological evaluations play a critical role in immigration cases by providing objective, clinical insight into emotional, cognitive, and psychological factors that may affect an individual or their qualifying family members. In asylum cases, evaluations help document trauma-related symptoms, emotional distress, and long-term psychological impact tied to persecution or fear of return. These assessments are carefully prepared to align with legal standards and support immigration filings with clear, evidence-based findings.

For cases involving extreme hardship waivers, Pro Psychological Analysis conducts evaluations that assess the emotional and psychological consequences a qualifying relative may face if separation occurs. These reports are commonly used to support waiver applications by illustrating the depth and severity of hardship in a professional, clinically sound manner. Each evaluation is completed with attention to accuracy, clarity, and legal relevance.

Pro Psychological Analysis works closely with legal professionals to ensure psychological evaluations are thorough, confidential, and compliant with applicable ethical and clinical guidelines. The firm’s approach emphasizes neutrality, professionalism, and detailed reporting, offering immigration attorneys reliable documentation to strengthen case presentation.

Please visit Pro Psychological Analysis’s website for more information about psychological evaluations for immigration matters, including support for asylum claims and extreme hardship waivers.

About Pro Psychological Analysis
Pro Psychological Analysis provides comprehensive psychological evaluation services tailored to immigration-related legal needs. The practice is dedicated to delivering high-quality, ethically sound assessments that assist attorneys and individuals in presenting well-supported immigration cases across the United States.

Media Contact:
Content Editor
Website: https://ppanalysis.com/

The Press Department
BrandRep, LLC
+1 855-800-2833
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Omen Kaine’s The Heart Tells Tales A Runaway Hit!

BROOKLYN, NY, UNITED STATES, March 17, 2026 /EINPresswire.com/ — Playwright and creator Omen Kaine is captivating audiences and critics alike as his bold and emotionally charged stage production, The Heart Tells Tales, emerges as one of the most talked-about new works in contemporary theater. Following sold-out runs in Los Angeles and New York, Kaine’s acclaimed production is now expanding into film development and an international jazz musical adaptation, signaling the rapid rise of a distinctive new voice in theater and storytelling.

The Heart Tells Tales premiered at the Skiptown Theater in Los Angeles in November 2025, featuring leads Danny Hackin and Fred Thomas, with Ashley Kay, Jenn Brown, Kat Johnston and Justin Vanhpraseuth rounding out the ensemble. The production sold out every performance, driven by powerful word-of-mouth and passionate audience response.

Building on that momentum, the production moved to New York’s Under St. Marks Theater, with a new cast led by Matthew Conkling, Pierce Bunch, and Dewitt Gilmore, supported by Felica Nadine, Paige Noelle, Bonnie Schneider, Joseph Dalton, and Janna Bastone. The New York engagement replicated the same box-office success, earning critical acclaim and expanding The Heart Tells Tales’ reputation as a must-see theatrical experience.

Expansion into Film and Music
Kaine’s production company, Hi Fi Underground Productions, has begun development on a cinematic adaptation of The Heart Tells Tales, produced by Jonathan Henderson and Ruben Anavitate. The project marks the first step in bringing Kaine’s theatrical world to the screen.

Meanwhile, across the Atlantic, an innovative jazz musical adaptation is in negotiation in Brussels, Belgium, with Stephane Mercier—an acclaimed saxophonist and Berklee College of Music graduate—and his son, keyboardist Mael Idris, both of the Clandestine Circle Quintet. This new version aims to transform the play’s emotional depth into a dynamic and soulful jazz performance.

The adaptation is also being considered for inclusion in the 2026 Théâtre Marni Jazz Festival, with growing interest from multiple European venues.

National and International Attention
With its bold storytelling and cross-medium expansion, Kaine’s work is drawing increasing national media attention. A recent feature in the NY Daily News highlights his ambition to create an interconnected creative universe spanning theater, film, and music.

Read the full article here: https://www.nydailynews.com/2026/03/12/omen-kaine-is-building-a-universe-and-audiences-are-starting-to-pay-attention/

About Omen Kaine
Omen Kaine is a playwright, director, and founder of Hi Fi Underground Productions, dedicated to developing original works that push artistic boundaries across stage, film, and music.

Media Contact:
Hi Fi Underground Productions
Press Office
Email: hifiunderground93@gmail.com

Omen kaine
Hi Fi Underground
hifiunderground93@gmail.com
Visit us on social media:
Instagram
Facebook
YouTube

SOLD OUT The Heart Tells Tales LA Shows!!!

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

ISO 17025 Lab Provides FDA, GMP, and Amazon Compliance Support for Supplement & Pharma Brands

IRVINE, CA, UNITED STATES, March 17, 2026 /EINPresswire.com/ — Qalitex Laboratories, an ISO 17025-accredited testing laboratory offering regulatory consulting services for supplement and pharmaceutical brands across North America, today addressed the growing FDA regulatory compliance challenges that dietary supplement manufacturers and pharmaceutical developers face in 2026 — including increased inspection frequency, expanded import alert coverage, and the growing complexity of Amazon compliance documentation requirements.

FDA’s enforcement posture toward dietary supplement manufacturers has intensified over the past several years. The agency has increased the frequency of cGMP inspections for dietary supplement facilities, and a significant percentage of inspections result in Form 483 observations — written notices identifying conditions that may constitute violations of the Food, Drug, and Cosmetic Act. The most commonly cited violations involve failures in identity testing for incoming raw materials, inadequate batch production records, and missing or insufficient written laboratory procedures.

For pharmaceutical developers, the regulatory landscape presents different but equally complex challenges. IND application CMC sections require stability data, analytical method validation packages, and manufacturing process descriptions that meet FDA’s current expectations, which have evolved with new guidance on elemental impurities (ICH Q3D), nitrosamine impurities, and drug substance characterization.

“What we see most often when a brand comes to us after receiving a Form 483 or warning letter is that the underlying issue was a quality system gap present for some time,” said Nour Abochama, Vice President of Operations at Qalitex Laboratories. “The inspection just made it visible. Our regulatory consulting work focuses on helping brands find and close those gaps before an inspection — not after. A mock audit conducted six months before an FDA inspection is far more valuable than a warning letter response written six weeks afterward.”

Qalitex’s regulatory consulting practice includes:

FDA warning letter response strategy and corrective action planning

cGMP gap analysis against 21 CFR Part 111 (dietary supplements) and 21 CFR Part 211 (pharmaceuticals)

Mock FDA inspection services with written reports and prioritized corrective action recommendations

SOP library development and review

Product label review and structure/function claims analysis

Health Canada NHP regulatory support for brands seeking Canadian market entry

For Amazon FBA sellers, regulatory compliance has taken on new dimensions as Amazon has expanded documentation requirements for supplements and cosmetics. Seller Central compliance programs now require Certificates of Analysis from ISO-accredited laboratories, heavy metal testing documentation, microbiology reports, and, in some categories, stability data. Sellers unable to provide compliant documentation risk listing suspension, account holds, and inventory removal.

The combination of laboratory testing and regulatory consulting provides a significant advantage for brands working with Qalitex. When regulatory consulting identifies a need for specific testing data — whether for an FDA response, retailer audit, or Amazon compliance hold — testing can be initiated immediately within the same organization, with results integrated directly into the regulatory response.

“The brands that navigate FDA compliance most successfully are the ones that treat it as a quality system investment rather than a compliance checkbox,” said Nour Abochama. “When we conduct a mock audit, we don’t just report violations — we identify the gaps an FDA investigator would find so the brand can address them proactively. That preparation makes a real difference.”

Resources:
Full article: https://qalitex.com/services/regulatory-consulting/

About Qalitex Laboratories
Qalitex Laboratories is an ISO 17025-accredited third-party analytical testing laboratory with facilities in Irvine and San Diego, California. The laboratory provides certificate of analysis (COA) testing, heavy metal analysis by ICP-MS, microbiology testing per USP and , preservative efficacy testing, stability studies under ICH guidelines, and regulatory compliance support for dietary supplement brands, cosmetic companies, and consumer goods manufacturers. Turnaround times start at 48 hours for standard panels. Testing programs meet 21 CFR Part 111, California Proposition 65, Amazon supplement compliance requirements, and Health Canada NHP Directorate standards.

Nour Abochama
Qalitex Laboratories
+1 949-881-6661
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

ISO 17025-accredited California lab offers HPLC, LC-MS/MS, ICP-MS, and ICH stability studies with 48-hour turnaround for FDA submissions.

IRVINE, CA, UNITED STATES, March 17, 2026 /EINPresswire.com/ — Qalitex Laboratories, an ISO 17025-accredited third-party analytical testing laboratory serving pharmaceutical developers, contract research organizations (CROs), and dietary supplement brands across North America, today highlighted the pharmaceutical testing requirements that drug developers and small biotechs must address when preparing IND and NDA submissions to the FDA — and how analytical chemistry testing, stability studies, and method validation integrate into the regulatory timeline.

FDA requirements for pharmaceutical analytical testing are governed by ICH guidelines, which define standards for stability testing, method validation, and impurity profiling. ICH Q1A(R2) establishes stability testing requirements for new drug substances and products, including storage conditions, testing intervals, and the data package required for regulatory submissions. ICH Q2(R1) defines validation requirements for analytical procedures, including specificity, linearity, range, accuracy, precision, and detection and quantitation limits.

For drug developers preparing IND filings, stability data is a mandatory component of the chemistry, manufacturing, and controls (CMC) section. FDA requires data demonstrating that the drug substance and product maintain acceptable quality throughout the proposed shelf life. For early-stage IND submissions, accelerated stability data at 40°C / 75% RH per ICH Q1A(R2) is typically required, with long-term stability studies at 25°C / 60% RH initiated at the time of filing.

“The challenge for small drug developers and biotechs is that large CROs often have 6-to-12-week wait times for routine analytical testing and stability program initiation,” said Nour Abochama, Vice President of Operations at Qalitex Laboratories. “When you’re working toward an IND filing deadline, that timeline can be a significant constraint. We built our pharmaceutical testing program to provide CRO-quality analytical results — validated methods, ICH-compliant stability chambers, pharmaceutical-grade QC documentation — with turnaround times that align with real development schedules.”

Qalitex’s pharmaceutical analytical testing capabilities include:

HPLC and UPLC for identity, potency, and purity

LC-MS/MS for impurity profiling and trace-level quantitation

ICP-MS for elemental impurity analysis per ICH Q3D

GC-MS for residual solvent testing per USP and ICH Q3C

Dissolution testing per USP

Content uniformity per USP

All methods are validated per ICH Q2(R1) or developed against applicable USP monographs.

Stability testing at Qalitex is conducted in ICH-qualified chambers with continuous temperature and humidity monitoring and automated data logging. The laboratory offers long-term stability at 25°C / 60% RH (ICH Zone II), intermediate at 30°C / 65% RH, and accelerated at 40°C / 75% RH, with testing at ICH-specified time points of 0, 3, 6, 9, 12, 18, 24, and 36 months. Photostability testing per ICH Q1B is also available.

California’s life sciences sector includes more than 3,000 companies, with a significant concentration of small and mid-size drug developers and biotechs in the San Diego and Los Angeles corridors. Many lack in-house analytical testing infrastructure and rely on contract testing laboratories for both development-stage and commercial-stage analytical work.

“The questions that matter most when a pharmaceutical developer evaluates a testing laboratory are about method validation and regulatory defensibility,” said Abochama. “Is the method validated for your specific matrix? What reference standards were used? Is the stability chamber ICH-qualified with continuous monitoring? Can you provide the validation data for inclusion in your regulatory submission? We answer these questions directly, and the documentation we provide is designed to be submission-ready.”

All pharmaceutical testing at Qalitex is performed under FDA 21 CFR Part 211 cGMP guidelines alongside ISO 17025 accreditation standards.

Resources:
Full article: https://qalitex.com/services/pharmaceutical-testing/

About Qalitex Laboratories
Qalitex Laboratories is an ISO 17025-accredited third-party analytical testing laboratory with facilities in Irvine and San Diego, California. The laboratory provides certificate of analysis (COA) testing, heavy metal analysis by ICP-MS, microbiology testing per USP and , preservative efficacy testing, stability studies under ICH guidelines, and regulatory compliance support for dietary supplement brands, cosmetic companies, and consumer goods manufacturers. Turnaround times start at 48 hours for standard panels. Testing programs meet 21 CFR Part 111, California Proposition 65, Amazon supplement compliance requirements, and Health Canada NHP Directorate standards.

Nour Abochama
Qalitex Laboratories
+1 949-881-6661
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.